Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01548417 · ClinicalTrials.gov registry record · Phase 2
Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists
A Phase 2 study, sponsored by The Scripps Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
NCT01548417 is a Phase 2 study that has completed, run by The Scripps Research Institute. The registered enrollment target is 56 participants.
The verdict
NCT01548417, a Phase 2 study, has completed, sponsored by The Scripps Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
Study Summary
The primary hypotheses under test are that alcohol dependent subjects treated with mifepristone will report decreased craving for alcohol following alcohol exposure in the laboratory and report significantly less drinking under naturalistic conditions, than those treated with placebo.
Interventions
- DRUG Sugar Pill
- DRUG Korlym (mifepristone)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01548417
The ClinicalTrials.gov registry entry for NCT01548417 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Scripps Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sugar Pill is the first listed.
NCT01548417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01548417 about?
NCT01548417 is a clinical study titled "Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists". The primary hypotheses under test are that alcohol dependent subjects treated with mifepristone will report decreased craving for alcohol following alcohol exposure in the laboratory and report significantly less drinking under naturalistic conditions, than those treated with placebo.
What is the current status of trial NCT01548417?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2012-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01548417?
The interventions under investigation include: Sugar Pill (DRUG), Korlym (mifepristone) (DRUG).
Who is sponsoring clinical trial NCT01548417?
This trial is sponsored by The Scripps Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.